Latest Regulation News

Resources & Energy Group Limited (REZ) has resumed trial gold mining at its East Menzies Gold Project, focusing on the Maranoa deposit with a vat leach method. The company anticipates its first gold pour on February 1, 2025, marking a pivotal step toward sustained production.

Riversgold Ltd has submitted a Mining Lease application for its Northern Zone Gold Project near Kalgoorlie and reported outstanding high-grade rock chip results from its Saint John Copper Gold Silver Antimony Project in New Brunswick, Canada.

Heavy Minerals Limited advances steadily on its Port Gregory Garnet Project, with the Pre-Feasibility Study nearing completion and critical permitting and sales groundwork underway.

NT Minerals reports exceptional copper assay results from its Twin Peaks Project in Western Australia, alongside strategic option agreements that could reshape its Northern Territory portfolio.

Theta Gold Mines has made significant strides in developing its TGME Gold Plant, securing $6 million in private equity and progressing an EPC contract with PowerChina's subsidiary. The company is also integrating surface gold resources into its mining schedule and advancing environmental and social governance initiatives.

APC Minerals Limited reports significant progress in its Laverton Downs gold exploration program alongside a corporate rebranding and capital consolidation, positioning the company for its next growth phase.

Althea Group Holdings has obtained Federal Court orders confirming the validity of past share sales despite previous failures to lodge required Cleansing Notices, paving the way for the reinstatement of its shares to trading.

Pearl Gull Iron Limited reports steady progress in exploration planning on Cockatoo Island despite seasonal challenges, maintaining environmental commitments and exploring new asset opportunities.

Western Gold Resources Limited has secured expanded mining approvals, confirmed strong metallurgical recoveries, and updated its mineral resource estimate at the Gold Duke Project, positioning the company for a transition to production.

Paradigm Biopharmaceuticals has launched a Loyalty and Piggyback Options program aimed at rewarding shareholders and raising up to $111.96 million to support its pivotal Phase III clinical trial.

Alexium International Group reports a 16% sales increase in Q2 FY25 despite ongoing mattress market softness, driven by strategic product diversification and supply chain improvements.

Epsilon Healthcare's December 2023 quarterly report reveals significant boardroom conflict and governance breaches, yet operational segments show promising growth.